About AER Therapeutics
AER Therapeutics is a private company based in Research Triangle Park, North Carolina. It has reported $23,882,384 raised in three offerings on Form D since December 2022. Its chief executive is Thomas Mathers.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Aug 7, 2026 | Aug 19, 2026 | $3,000,000fully sold | 7 | $428K | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Jan 24, 2025 | Feb 7, 2025 | $5,000,000fully sold | 15 | $333K | EquityRule 506(b) | Form D ↗ |
| Dec 9, 2022 | Dec 22, 2022 | $15,882,384of $36.8M target | 23 | $690K | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $23,882,384 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on AER Therapeutics's Form D filed Aug 19, 2026.
Evan Caplan
Partner, OrbiMed and director
Tim Shannon
Partner, Canaan Partners and director
Christy Shaffer
Partner, Hatteras Ventures and director
Earlier filings also listed Rishi Gupta (director, last listed Feb 2025) and James Shaffer (ceo and director, last listed Dec 2022).